Summary
Katharina Hauck is a Professor in Health Economics and Deputy Director of the Abdul Latif Jameel Institute for Disease and Emergency Analytics (Jameel Institute), School of Public Health, Imperial College London. She is specialized in the economics of infectious diseases and the economic evaluation of complex public health interventions. Her research focuses on the economics of pandemic preparedness, the economics of malaria elimination, cost-effectiveness analysis, and health system strengthening.
Katharina leads the recently launched 'Jameel Institute-Kenneth C. Griffin Initiative for the Economics of Pandemic Preparedness', an international collaborative program of research that has the mission to determine the societal and economic value of pandemic preparedness with integrated economic-epidemiological modelling.
Katharina also leads several collaborative studies in low-and middle-income countries, including the economic evaluation of HPTN071/PopART, a landmark study on the impact of a combination prevention package on population-level HIV incidence in Zambia and South Africa, and STARmeds, a study on falsified and substandard medicines in Indonesia. She is co-convener of the economic analysis for the Infected Blood Inquiry in the United Kingdom.
Katharina regularly advises on national and international health policy related to the economics of infectious diseases, including for WHO, the Global Fund, governments of low-and middle income countries, and the UK Cabinet Office. She is an associate editor for the journal 'Health Economics'.
Katharina holds a PhD in Economics from the University of York (2005). Her previous appointments were at the Business School of Imperial College London (2010-2015), the Department of Econometrics and Business Statistics, Monash University (Australia, 2005-2010), the Centre for Health Economics, University of York (UK, 1999-2005), and the World Health Organization in Geneva (Switzerland, 1998-1999).
Selected Publications
Journal Articles
Olivera Mesa D, Winskill P, Ghani AC, et al., 2023, The societal cost of vaccine refusal: A modelling study using measles vaccination as a case study., Vaccine, Vol:41, Pages:4129-4137
Johnson R, Djaafara B, Haw D, et al., 2023, The societal value of SARS-CoV-2 booster vaccination in Indonesia, Vaccine, Vol:41, ISSN:0264-410X, Pages:1885-1891
Haw D, Forchini G, Doohan P, et al., 2022, Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS, Nature Computational Science, Vol:2, ISSN:2662-8457, Pages:223-233
Galizzi M, Lau K, Miraldo M, et al., 2022, Bandwagoning, free-riding and heterogeneity in influenza vaccine decisions: an online experiment, Health Economics, Vol:31, ISSN:1057-9230, Pages:614-646
Thomas R, Probert W, Sauter R, et al., 2021, Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial, The Lancet Global Health, Vol:9, ISSN:2214-109X, Pages:e668-e680
Christen P, D'Aeth J, Lochen A, et al., 2021, The J-IDEA pandemic planner: a framework for implementing hospital provision interventions during the COVID-19 pandemic, Medical Care, Vol:59, ISSN:0025-7079, Pages:371-378
Singh S, Shaikh M, Hauck K, et al., 2021, Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States, Proceedings of the National Academy of Sciences of the United States of America, Vol:118, ISSN:0027-8424
Chapters
Hauck KD, 2018, The economics of infectious diseases, Oxford Research Encyclopedia of Economics and Finance, Editor(s): Jones, Oxford University Press
Reports
Hauck K, McCrone P, Hallett T, et al., 2023, Expert report to the infected blood inquiry: health economics, Expert Report to the UK Infected Blood Inquiry: Health Economics, London, UK, Infected Blood Inquiry UK